Exelixis Inc (EXEL)
23.29
+0.42
(+1.84%)
USD |
NASDAQ |
Apr 23, 16:00
23.28
0.00 (0.00%)
After-Hours: 20:00
Exelixis Gross Profit Margin (Quarterly): 95.46% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 95.46% |
| September 30, 2023 | 96.02% |
| June 30, 2023 | 96.23% |
| March 31, 2023 | 96.50% |
| December 31, 2022 | 96.24% |
| September 30, 2022 | 96.28% |
| June 30, 2022 | 96.79% |
| March 31, 2022 | 96.29% |
| December 31, 2021 | 97.14% |
| September 30, 2021 | 96.38% |
| June 30, 2021 | 96.14% |
| March 31, 2021 | 95.12% |
| December 31, 2020 | 96.65% |
| September 30, 2020 | 96.22% |
| June 30, 2020 | 96.45% |
| March 31, 2020 | 95.91% |
| December 31, 2019 | 95.62% |
| September 30, 2019 | 97.23% |
| June 30, 2019 | 96.86% |
| March 31, 2019 | 96.52% |
| December 31, 2018 | 96.78% |
| September 30, 2018 | 96.73% |
| Date | Value |
|---|---|
| June 30, 2018 | 96.78% |
| March 31, 2018 | 97.36% |
| December 31, 2017 | 96.51% |
| September 30, 2017 | 96.95% |
| June 30, 2017 | 96.96% |
| March 31, 2017 | 96.04% |
| December 31, 2016 | 97.61% |
| September 30, 2016 | 96.05% |
| June 30, 2016 | 95.70% |
| March 31, 2016 | 95.56% |
| December 31, 2015 | 89.71% |
| September 30, 2015 | 85.59% |
| June 30, 2015 | 91.42% |
| March 31, 2015 | 91.84% |
| December 31, 2014 | 90.70% |
| September 30, 2014 | 90.89% |
| June 30, 2014 | 92.73% |
| March 31, 2014 | 93.70% |
| December 31, 2013 | 93.95% |
| September 30, 2013 | 94.69% |
| June 30, 2013 | 97.60% |
| March 31, 2013 | 97.10% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
95.12%
Minimum
Mar 2021
97.23%
Maximum
Sep 2019
96.29%
Average
96.28%
Median
Sep 2022
Gross Profit Margin (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 84.95% |
| Bristol-Myers Squibb Co | 76.08% |
| Johnson & Johnson | 69.55% |
| Bio-Techne Corp | 64.78% |
| Legend Biotech Corp | 59.16% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 8.53% |
| Return on Assets | 6.80% |
| Return on Invested Capital | 8.53% |
| Profit Margin (Quarterly) | 17.83% |
| Operating Margin (Quarterly) | 17.05% |
| Return on Net Operating Assets | 27.75% |